Simulations Plus to Present at Baird 2022 Global Healthcare Conference
09/07/2022 - 08:30 AM
LANCASTER, Calif. --(BUSINESS WIRE)--
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at Baird’s 2022 Global Healthcare Conference taking place September 13-14, 2022 , at the InterContinental New York Barclay Hotel .
Shawn O’Connor, chief executive officer, will present on Wednesday, September 14, 2022 , at 2:00 p.m. ET . The live webcast will be available on the Investors page of the Simulations Plus website and archived for replay.
For more information about the Baird Global Healthcare Conference , or to register to attend, please visit the conference website or contact Brian Siegel from Hayden IR at brian@haydenir.com .
About Simulations Plus
Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com . Follow us on Twitter | LinkedIn .
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report
View source version on businesswire.com : https://www.businesswire.com/news/home/20220907005602/en/
Simulations Plus Investor Relations
Renee Bouche
renee.bouche@simulations-plus.com
Hayden IR
Brian Siegel
brian@haydenir.com
Source: Simulations Plus
Simulations Plus Inc.
NASDAQ:SLP
SLP Rankings
#3207 Ranked by Stock Gains
SLP Stock Data
Industry
Computer Systems Design Services
Sector
Professional, Scientific, and Technical Services
Tags
Technology Services, Packaged Software, Professional, Scientific, and Technical Services, Computer Systems Design Services
Country
US
City
Lancaster
About SLP
simulations plus, inc. (nasdaq: slp) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. we partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post approval. with our subsidiaries, cognigen corporation and dilisym services, we offer #1-ranked, easy-to-use software (gastroplus™, admet predictor™, kiwi™, dilisym®, nafldsym®, pkplus™, and more) to bridge data mining, compound library screening with qsar models, pbpk/tk modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. simulations plus technology is licensed to and used by regulatory agencies worldwide. for over 20 years, simulations plus has partnered with our clients to reduce costs and accelerate res
